Ronald E. Blaylock's Insider Trades & SAST Disclosures
Ronald E. Blaylock's most recent trade in Pfizer Inc. was a trade of 8,999 Phantom Stock Units done . Disclosure was reported to the exchange on April 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Ronald E. Blaylock.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer Inc. | Ronald E. Blaylock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2025 | 8,999 | 71,373 | - | - | Phantom Stock Units | |
| Pfizer Inc. | Ronald E. Blaylock | Director | Purchase of securities on an exchange or from another person at price $ 25.65 per share. | 13 Feb 2025 | 19,457 | 27,707 (0%) | 0% | 25.6 | 499,072 | Common Stock |
| Carmax Inc | Ronald E. Blaylock | Director | 01 Jul 2024 | 2,598 | 12,658 (0%) | 0% | 0 | Common Stock | ||
| W.R. Berkley Corp. | Ronald E. Blaylock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,534 | 77,416 (0%) | 0% | 0 | Common Stock | |
| Pfizer Inc. | Ronald E. Blaylock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 8,115 | 58,627 | - | - | Phantom Stock Units | |
| Carmax Inc | Ronald E. Blaylock | Director | 30 Jun 2023 | 2,210 | 10,060 (0%) | 0% | 0 | Common Stock | ||
| W.R. Berkley Corp. | Ronald E. Blaylock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 3,479 | 74,882 (0%) | 0% | 0 | Common Stock | |
| Pfizer Inc. | Ronald E. Blaylock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 5,291 | 47,972 | - | - | Phantom Stock Units | |
| Carmax Inc | Ronald E. Blaylock | Director | 01 Jul 2022 | 1,996 | 7,850 (0%) | 0% | 0 | Common Stock | ||
| W.R. Berkley Corp. | Ronald E. Blaylock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 2,995 | 71,404 (0%) | 0% | 0 | Common Stock | |
| Advantage Solutions Inc. -... | Ronald E. Blaylock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 40,603 | 90,303 | - | 0 | Class A Common Stock | |
| Pfizer Inc. | Ronald E. Blaylock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 4,058 | 41,235 | - | - | Phantom Stock Units | |
| Carmax Inc | Ronald E. Blaylock | Director | 16 Jul 2021 | 12,500 | 5,854 (0%) | 0% | 132.0 | 1,650,250 | Common Stock | |
| Carmax Inc | Ronald E. Blaylock | Director | 02 Jul 2021 | 1,308 | 18,354 (0%) | 0% | 0 | Common Stock | ||
| Pfizer Inc. | Ronald E. Blaylock | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Jun 2021 | 4,750 | 8,250 (0%) | 0% | 0 | Common Stock | |
| Pfizer Inc. | Ronald E. Blaylock | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Jun 2021 | 4,750 | 4,750 (0%) | 0% | 0 | Common Stock | |
| W.R. Berkley Corp. | Ronald E. Blaylock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 2,652 | 45,606 (0%) | 0% | 0 | Common Stock | |
| Advantage Solutions Inc. -... | Ronald E. Blaylock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 14,344 | 49,700 | - | 0 | Class A Common Stock | |
| Pfizer Inc. | Ronald E. Blaylock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2021 | 4,981 | 35,936 | - | - | Phantom Stock Units | |
| Advantage Solutions Inc. -... | Ronald E. Blaylock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 10,356 | 35,356 | - | 0 | Class A Common Stock | |
| Pfizer Inc. | Ronald E. Blaylock | Director | Purchase of securities on an exchange or from another person at price $ 38.49 per share. | 06 Aug 2020 | 4,000 | 4,000 (0%) | 0% | 38.5 | 153,960 | Common Stock |
| Pfizer Inc. | Ronald E. Blaylock | Director | Purchase of securities on an exchange or from another person at price $ 38.55 per share. | 06 Aug 2020 | 3,000 | 7,000 (0%) | 0% | 38.6 | 115,650 | Common Stock |
| Pfizer Inc. | Ronald E. Blaylock | Director | Purchase of securities on an exchange or from another person at price $ 38.56 per share. | 06 Aug 2020 | 2,500 | 9,500 (0%) | 0% | 38.6 | 96,400 | Common Stock |
| Pfizer Inc. | Ronald E. Blaylock | Director | Purchase of securities on an exchange or from another person at price $ 38.51 per share. | 06 Aug 2020 | 1,500 | 11,000 (0%) | 0% | 38.5 | 57,765 | Common Stock |
| Pfizer Inc. | Ronald E. Blaylock | Director | Purchase of securities on an exchange or from another person at price $ 38.69 per share. | 06 Aug 2020 | 1,000 | 12,000 (0%) | 0% | 38.7 | 38,690 | Common Stock |
| Pfizer Inc. | Ronald E. Blaylock | Director | Purchase of securities on an exchange or from another person at price $ 38.62 per share. | 06 Aug 2020 | 1,000 | 13,000 (0%) | 0% | 38.6 | 38,620 | Common Stock |
| Carmax Inc | Ronald E. Blaylock | Director | 13 Jul 2020 | 10,200 | 17,046 (0%) | 0% | 89.4 | 911,574 | Common Stock | |
| Carmax Inc | Ronald E. Blaylock | Director | 26 Jun 2020 | 2,021 | 27,246 (0%) | 0% | 0 | Common Stock | ||
| W.R. Berkley Corp. | Ronald E. Blaylock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 3,483 | 42,954 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges